Home MSSP ACO

Shared Savings Program Public Reporting

ACO Name and Location
HealthChoice, LLC
Trade Name/DBA:  Aledade HealthChoice MSSP Enhanced 
1661 International Place Drive, Suite 130
Memphis, TN  38120, U.S.A.
 
 
ACO Primary Contact:  
Primary Contact Name: Blayne Burns
Primary Contact Phone Number: 901-821-6739
Primary Contact Email Address: Blayne.Burns@myhealthchoice.com
 
 
Organizational Information:  

        ACO Participants
ACO Participant in
Joint Venture
Primary Care Group, LLC No
Progressive Physicians Practice No

 

ACO Governing Body:
      Member's    
      Voting Power   ACO Participant
------------------ MEMBER ------------------ (expressed as Membership Legal Business Name
Member First Name Member Last Name Member Title/ Position a percentage) Type (if applicable)
           
  Michael   Ugwueke     CEO 20.00 % ACO Participant  Representative Primary Care
Group, LLC
 
  Marigay   Miller     VP 20.00 % ACO Participant
Representative
Primary Care
Group, LLC
 
   Monica   Wharton      COO 20.00 % ACO Participant Representative  Primary Care
Group, LLC
 
  Jimmie   Mancell     MD   0 % Community
Stakeholder
Representative
N/A

 
  Whitney   Slade     MD 20.00 % ACO Participant
Representative
Primary Care
Group, LLC
 
  Arvind  Ankireddypalli     MD 20.00 % ACO Participant
Representative
Primary Care
Group, LLC
 
  Carter   Towne     MD  0 % Medicare
Beneficiary
Representative
     N/A

 
Member's voting power may have been rounded to reflect a total voting power of 100 percent.

 

Key ACO Clinical and Administrative Leadership:
ACO Executive Arthur Townsend, MD
Medical Director Arthur Townsend, MD
Compliance Officer Adam Barker
Quality Assurance/Improvement Officer   Cindy Lusk
   

 

 
Associated Committees and Committee Leadership:
Committee Name Committee Leader Name and Position
N/A N/A
           

 

 
Types of ACO Participants, or Combination of Participants, That Formed the ACO:
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

 

 
Shared Savings and Losses:
Amount of Shared Savings and Losses:  
  • Third Agreement Period
    • Performance Year 2026, N/A 
    • Performance Year 2025, N/A 
    • Performance Year 2024, $6,606,389.89  
  • Second Agreement Period
    • Performance Year 2023, $1,394,955.37 
    • Performance Year 2022, $0.00 
  • First Agreement Period
    • Performance Year 2021, $3,221,757.09 
    • Performance Year 2020, $0.00 
    • Performance Year 2019, $0.00 
    • Performance Year 2018, $0.00
 
Shared Savings Distribution:  
  • Third Agreement Period
    • Performance Year 2026
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A 
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2025
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A 
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2024
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 50% 
      • Proportion of distribution to ACO participants: 35%
  • Second Agreement Period
    • Performance Year 2023
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 50% 
      • Proportion of distribution to ACO participants: 40%
    • Performance Year 2022
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A 
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2021
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: --- 
      • Proportion of distribution to ACO participants: 85%
    • Performance Year 2020
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A 
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2019
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A 
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2018
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A 
      • Proportion of distribution to ACO participants: N/A
 
Quality Performance Results 
2024 Quality Performance Results:
Quality performance results are based on the CMS Web Interface collection type.
Measure #   Measure Title Collection
Type



Performance
Rate
Current
Year Mean
Performance
Rate
(SSP ACOs)
321   CAHPS for MIPS 
 
CAHPS for MIPS Survey 2.1 6.67
479*   Hospital-Wide, 30-Day, All-Cause Unplanned
Readmission (HWR) Rate for MIPS Groups
 
Administrative Claims 0.1612 0.1517
484*   Clinician and Clinician Group Risk-standardized
Hospital Admission Rates for Patients with Multiple
Chronic Conditions 
 
Administrative Claims -- 37
318   Falls: Screening for Future Fall Risk
 
CMS Web Interface 98.77 88.99
110   Preventative Care and Screening: Influenza
Immunization
 
CMS Web Interface 78.81 68.6
226   Preventative Care and Screening: 
Tobacco Use: Screening and Cessation Intervention
 
CMS Web Interface 100 79.98
113   Colorectal Cancer Screening
 
CMS Web Interface 82.48 77.81
112   Breast Cancer Screening
 
CMS Web Interface 81.56 80.93
438   Statin Therapy for the Prevention and Treatment of
Cardiovascular Disease
 
CMS Web Interface 93.59 86.5
370   Depression Remission at Twelve Months
 
CMS Web Interface 19.48 17.35
001*   Diabetes: Hemoglobin A1c (HbA1c) Poor Control [1] 
 
CMS Web Interface 6.45 9.44
134   Preventative Care and Screening: Screening for
Depression and Follow-up Plan
 
CMS Web Interface 89.66 81.46
236   Controlling High Blood Pressure
 
CMS Web Interface 76.07 79.49
CAHPS-1    Getting Timely Care, Appointments, and
Information
 
CAHPS for MIPS Survey 75.9 83.7
CAHPS-2    How Well Providers Communicate
 
CAHPS for MIPS Survey 88.62 93.96
CAHPS-3    Patient's Rating of Provider
 
CAHPS for MIPS Survey 88.04 92.43
CAHPS-4    Access to Specialists
 
CAHPS for MIPS Survey 75.02 75.76
CAHPS-5    Health Promotion and Education
 
CAHPS for MIPS Survey 53.78 65.48
CAHPS-6    Shared Decision Making
 
CAHPS for MIPS Survey 54.79 62.31
CAHPS-7    Health Status and Functional Status
 
CAHPS for MIPS Survey 69.72 74.14
CAHPS-8    Care Coordination
 
CAHPS for MIPS Survey 80.08 85.89
CAHPS-9   Courteous and Helpful Office Staff
 
CAHPS for MIPS Survey 88.65 92.89
CAHPS-11   Stewardship of Patient Resources
 
CAHPS for MIPS Survey 18.28 26.98
For previous years’ Financial and Quality Performance Results, Please Visit data.cms.gov .
 
*For Diabetes:  Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinical Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
 
*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative payment Model (APM) Participants (QPs).  Most providers participating in Track E and ENHANCED rack ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs' providers overall.  Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.